GO:0032653 regulation of interleukin-10 production: Immune Regulation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032653 (regulation of interleukin-10 production) describes any biological process that modulates the frequency, rate, or extent of interleukin-10 (IL-10) production, including its biosynthesis and secretion.
• IL-10 is a pleiotropic anti-inflammatory cytokine whose production is tightly controlled at transcriptional, post-transcriptional, and metabolic levels in both innate and adaptive immune cells.
• Key cell types that produce IL-10 include CD4+ T cells (Th2, Th1, Th17, Treg, Tr1), B cells, plasma cells, macrophages, dendritic cells, and natural killer cells.
• Dysregulated IL-10 production is implicated in chronic infections, autoimmunity, inflammatory bowel disease, and cancer, making its regulatory pathways attractive therapeutic targets.
• Metabolic and mitochondrial checkpoints, such as lipid metabolism and mitochondrial integrity, can cell-intrinsically regulate Treg suppressive function and IL-10 production.
• CRISPR-based knockout, knock-in, point-mutation, and overexpression models are powerful tools to dissect the causal roles of specific genes in the regulation of IL-10 production.
Description
Interleukin-10 (IL-10) is a master anti-inflammatory cytokine that limits immunopathology but can also promote pathogen persistence and tumor immune evasion. The Gene Ontology term GO:0032653, regulation of interleukin-10 production, captures any process that modulates the frequency, rate, or extent of IL-10 production, encompassing transcriptional, post-transcriptional, and secretory control mechanisms. Understanding this regulatory node is essential because IL-10 levels must be finely tuned: too little IL-10 leads to excessive inflammation and tissue damage, while too much IL-10 can suppress protective immunity and facilitate chronic infection or cancer progression. Research over the past two decades has revealed that IL-10 production is not restricted to a single cell type or pathway. Multiple immune cell populations, including CD4+ T cell subsets, regulatory T cells (Tregs), B cells, plasma cells, macrophages, and dendritic cells, produce IL-10 in response to diverse stimuli. The regulation of IL-10 production involves a complex interplay of transcription factors, epigenetic modifications, metabolic cues, and environmental signals. This complexity makes GO:0032653 a rich area for functional genomics and CRISPR-based interrogation. For researchers, GO:0032653 provides a structured framework to annotate genes and pathways that control IL-10 output. By integrating QuickGO annotations with experimental models, scientists can systematically test how specific perturbations alter IL-10 production and whether these changes affect disease outcomes. This article reviews the definition, mechanisms, key genes, disease relevance, and research methods associated with GO:0032653, with a focus on CRISPR-based approaches for causal validation.
regulation of interleukin-10 production At A Glance
| GO ID | GO:0032653 |
|---|---|
| GO term | regulation of interleukin-10 production |
| Ontology | biological_process |
| Definition | Any process that modulates the frequency, rate, or extent of interleukin-10 production. |
| Synonym | regulation of IL-10 production; regulation of interleukin-10 biosynthetic process; regulation of interleukin-10 secretion |
| Major function | Controls the amount of bioactive IL-10 released by immune and non-immune cells, thereby shaping anti-inflammatory and immunoregulatory responses. |
| Cell types involved | CD4+ T cells (Th1, Th2, Th17, Treg, Tr1), B cells, plasma cells, macrophages, dendritic cells, NK cells. |
| Key regulatory layers | Transcription, post-transcriptional stability, translation, secretion, and metabolic checkpoints. |
| Disease relevance | Autoimmunity, inflammatory bowel disease, chronic infections, cancer, and leukemia. |
What Is GO:0032653?
GO:0032653, regulation of interleukin-10 production, is a biological process defined as any process that modulates the frequency, rate, or extent of interleukin-10 production. This includes regulation of IL-10 biosynthesis, secretion, and overall output. The term is not limited to a single molecular mechanism; it encompasses transcriptional, post-transcriptional, translational, and secretory control points that collectively determine how much bioactive IL-10 is released by a cell. Synonyms include regulation of IL-10 production, regulation of interleukin-10 biosynthetic process, and regulation of interleukin-10 secretion.
Why Is regulation of interleukin-10 production Important in Cell Biology?
GO:0032653 is critically important because IL-10 is a central anti-inflammatory cytokine that prevents immunopathology but can also drive immune evasion in cancer and chronic infections. The regulation of IL-10 production determines the balance between protective immunity and tissue damage, and its dysregulation is associated with numerous human diseases, including inflammatory bowel disease, autoimmunity, and hematological malignancies. Understanding the molecular players that control IL-10 production can reveal therapeutic targets for modulating immune responses.
• IL-10 is a key anti-inflammatory cytokine that limits tissue damage during infection and autoimmunity.
• Dysregulated IL-10 production contributes to chronic inflammatory diseases such as inflammatory bowel disease.
• IL-10 can promote tumor immune evasion, and its regulation is relevant to cancer immunotherapy.
• Regulatory plasma cells are a major source of IL-10 and modulate immune responses in various disease settings.
• Metabolic and mitochondrial integrity checkpoints regulate Treg suppressive function and IL-10 production.
• CD73-dependent pathways regulate IL-10 in inflamed mucosa, linking purinergic signaling to IL-10 control.
• GPR120 activation inhibits colitis through regulation of CD4+ T cell IL-10 production, highlighting a druggable pathway.
• Statins can modulate IL-10 signaling and production in chronic lymphocytic leukemia cells.
• Understanding GO:0032653 aids in the development of therapies for autoimmune and inflammatory diseases.
• CRISPR screens can identify novel regulators of IL-10 production, accelerating target discovery.
What Happens During regulation of interleukin-10 production?
Transcriptional Control of IL-10 Expression
In simple terms: This step controls how much IL-10 mRNA is made from the IL10 gene.
Transcriptional regulation of the IL10 gene is a primary node in GO:0032653. Multiple transcription factors, including NF-κB, AP-1, STAT3, and MAF, bind to the IL10 promoter and enhancer regions to activate or repress transcription in a cell-type-specific manner. Epigenetic modifications, such as histone acetylation and DNA methylation, also influence IL10 transcription. In CD4+ T cells, the strength and duration of T cell receptor signaling, costimulation, and cytokine milieu shape the transcriptional program that drives IL-10 production.
Post-transcriptional and Translational Regulation
In simple terms: After mRNA is made, this step controls how stable it is and how much protein is produced.
IL-10 mRNA stability and translation are regulated by RNA-binding proteins and microRNAs that target the 3' untranslated region. For example, tristetraprolin (TTP) can destabilize IL-10 mRNA, while other factors may enhance its stability. Translational control allows cells to rapidly adjust IL-10 output without new transcription, which is important for fine-tuning immune responses.
Secretion and Extracellular Release
In simple terms: This step governs how IL-10 protein is packaged and released from the cell.
IL-10 is secreted as a homodimer through the classical secretory pathway. Regulation of secretion involves vesicular trafficking and can be influenced by cellular stress and metabolic state. The term GO:0032653 includes regulation of interleukin-10 secretion, as the amount of bioactive IL-10 available to bind its receptor depends on efficient release.
Metabolic and Mitochondrial Checkpoints
In simple terms: This step links the cell's energy and lipid status to its ability to produce IL-10.
Mitochondrial integrity and lipid metabolism act as cell-intrinsic checkpoints for Treg suppressive function and IL-10 production. Disruption of lipid metabolism can impair mitochondrial function and reduce IL-10 production, demonstrating that metabolic pathways are integral to GO:0032653. This crosstalk between metabolism and immune regulation is an emerging area of research.
Environmental and Receptor-mediated Signals
In simple terms: This step describes how external cues, such as metabolites or drugs, change IL-10 production.
G protein-coupled receptors and purinergic signaling can modulate IL-10 production. For instance, GPR120 activation inhibits colitis through regulation of CD4+ T cell IL-10 production. CD73-dependent adenosine signaling regulates interferon αA and IL-10 in inflamed mucosa. Statins can affect IL-10 signaling and production in chronic lymphocytic leukemia cells. These examples illustrate how environmental and pharmacological signals feed into GO:0032653.
Key Genes Involved in GO:0032653 regulation of interleukin-10 production
The following genes and proteins have been experimentally implicated in the regulation of interleukin-10 production (GO:0032653) based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL10 | Encodes the anti-inflammatory cytokine IL-10 | Central to GO:0032653; knockout and overexpression models are widely used. |
| STAT3 | Transcription factor that promotes IL-10 expression | Key transcriptional regulator; knockout reduces IL-10 production. |
| MAF | Transcription factor enhancing IL10 transcription in T cells | Controls IL-10 production in Tr1 and Th17 cells. |
| NFKB1 | Transcription factor activating IL10 promoter | Involved in inflammatory signaling and IL-10 induction. |
| PRDM1 (BLIMP1) | Transcriptional repressor that can regulate IL-10 | Modulates IL-10 production in T cells and plasma cells. |
| FOXP3 | Master transcription factor for Tregs | Tregs are major IL-10 producers; FOXP3 affects IL-10 expression. |
| GPR120 (FFAR4) | G protein-coupled receptor for omega-3 fatty acids | Activation inhibits colitis via CD4+ T cell IL-10 production. |
| CD73 (NT5E) | Ectoenzyme generating adenosine | Regulates IL-10 in inflamed mucosa. |
| HMGCR | Rate-limiting enzyme in cholesterol synthesis | Target of statins; statins affect IL-10 production in CLL cells. |
| TTP (ZFP36) | RNA-binding protein destabilizing IL-10 mRNA | Post-transcriptional control of IL-10 production. |
| mTOR | Kinase integrating metabolic signals | Metabolic checkpoint influencing Treg function and IL-10. |
| PPARG | Nuclear receptor regulating lipid metabolism | Lipid metabolism affects mitochondrial integrity and IL-10 production. |
| BACH2 | Transcription factor modulating IL-10 in B cells | Regulates regulatory B cell function and IL-10. |
| IRF4 | Transcription factor involved in IL-10 induction | Promotes IL-10 production in T cells and macrophages. |
| BATF | Transcription factor cooperating with IRF4 | Enhances IL-10 expression in T cells. |
| IL10RA | IL-10 receptor alpha subunit | Mediates IL-10 signaling feedback that can regulate production. |
| IL10RB | IL-10 receptor beta subunit | Part of IL-10 receptor complex; affects responsiveness. |
| SOCS3 | Suppressor of cytokine signaling | Negatively regulates IL-10 signaling and production. |
How Is regulation of interleukin-10 production Regulated?
The regulation of IL-10 production (GO:0032653) is itself subject to multiple layers of control. At the transcriptional level, transcription factors such as STAT3, MAF, IRF4, and BATF cooperate to activate the IL10 locus in response to immune stimuli. Post-transcriptional mechanisms, including mRNA stability and microRNA targeting, provide rapid tuning of IL-10 output. Metabolic pathways, particularly mitochondrial integrity and lipid metabolism, act as cell-intrinsic checkpoints for Treg suppressive function and IL-10 production. Environmental signals, such as omega-3 fatty acids acting through GPR120, can enhance IL-10 production in CD4+ T cells and ameliorate colitis. Adenosine signaling via CD73 also regulates IL-10 in inflamed mucosa. Pharmacological agents like statins can modulate IL-10 signaling and production in chronic lymphocytic leukemia cells. Together, these regulatory inputs ensure that IL-10 is produced at appropriate times and locations to maintain immune homeostasis.
regulation of interleukin-10 production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL10 | Inflammatory bowel disease, autoimmunity | IL10 knockout mice; CRISPR KO in human T cells. |
| GPR120 (FFAR4) | Colitis | GPR120 knockout mice; CD4+ T cell-specific KO. |
| CD73 (NT5E) | Mucosal inflammation | CD73 knockout mice; CRISPR KO in epithelial cells. |
| HMGCR | Chronic lymphocytic leukemia | Statin treatment in CLL cell lines; HMGCR KO. |
| FOXP3 | Autoimmunity, IPEX syndrome | FOXP3 knockout mice; CRISPR knock-in of patient mutations. |
Inflammatory Bowel Disease (IBD)
Dysregulated IL-10 production is strongly linked to IBD pathogenesis. GPR120 activation inhibits colitis through regulation of CD4+ T cell IL-10 production, suggesting that enhancing IL-10 production in T cells can be therapeutic. CD73-dependent regulation of IL-10 in inflamed mucosa further highlights the importance of local IL-10 control in intestinal inflammation. Genetic variants in IL10 or its receptor can lead to early-onset colitis, underscoring the critical role of GO:0032653 in intestinal immune homeostasis.
Cancer and Leukemia
IL-10 can promote tumor immune evasion by suppressing anti-tumor immunity. In chronic lymphocytic leukemia (CLL), statins affect IL-10 signaling and production by CLL cells, indicating that IL-10 regulation is relevant to leukemia biology and treatment. Elevated IL-10 production in the tumor microenvironment is associated with poor prognosis in several cancers, making GO:0032653 a potential target for cancer immunotherapy.
Autoimmunity
Reduced IL-10 production or impaired IL-10 signaling contributes to autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, and type 1 diabetes. Regulatory T cells and regulatory B cells that produce IL-10 are critical for suppressing autoreactive immune responses. Understanding the regulation of IL-10 production (GO:0032653) may inform strategies to boost IL-10 in autoimmune settings.
Chronic Infections
IL-10 is upregulated during many chronic infections and can prevent pathogen clearance. For example, CD73-dependent regulation of IL-10 in inflamed mucosa may affect host defense. Pathogens can exploit IL-10 production to evade immunity, and modulating GO:0032653 could be a therapeutic strategy in persistent infections.
From regulation of interleukin-10 production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate IL-10 production in CD4+ T cells? | CRISPR knockout of gene X in primary human or mouse CD4+ T cells followed by IL-10 ELISA. |
| Does a specific point mutation in gene Y affect IL-10 production? | CRISPR point mutation knock-in of the variant in a cell line or primary cells. |
| Does overexpression of gene Z enhance IL-10 production? | Lentiviral or CRISPR-mediated overexpression of gene Z in T cells or macrophages. |
| Does a tagged version of protein W localize with IL-10 secretory vesicles? | CRISPR knock-in of a fluorescent tag (e.g., GFP) at the endogenous locus. |
| Which metabolic pathways regulate IL-10 production in Tregs? | CRISPR knockout of metabolic genes (e.g., PPARG, mTOR) in Tregs followed by IL-10 measurement. |
| Can a drug modulate IL-10 production? | Pharmacological treatment (e.g., statins, GPR120 agonists) in wild-type and CRISPR KO cells. |
How to Study the regulation of interleukin-10 production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Genes affecting IL-10 production | Discovery of novel regulators in GO:0032653. |
| RNA-seq | Transcriptional changes | Pathway analysis in IL-10-producing cells. |
| Intracellular cytokine staining | Percentage of IL-10+ cells | Validation of CRISPR perturbations. |
| ELISA | Secreted IL-10 concentration | Quantification of IL-10 production. |
| Seahorse assay | Metabolic flux | Metabolic regulation of IL-10 in Tregs. |
| Lipidomics | Lipid species profiling | Lipid metabolism checkpoints. |
| Flow cytometry | Cell surface markers and viability | Phenotyping IL-10-producing cells. |
| Western blot | Protein expression and signaling | Validation of knockout or knock-in. |
CRISPR Knockout Screening
Genome-wide CRISPR knockout screens can identify genes that positively or negatively regulate IL-10 production. Cells are transduced with a sgRNA library, stimulated, and IL-10-producing cells are isolated by flow cytometry or cytokine capture. Sequencing of sgRNAs reveals enriched or depleted genes, providing unbiased discovery of regulators within GO:0032653.
RNA Sequencing and Transcriptomics
RNA-seq of cells under conditions that induce or repress IL-10 production can reveal transcriptional networks and pathways associated with GO:0032653. Comparing wild-type and CRISPR knockout cells identifies gene expression changes that correlate with IL-10 output.
Flow Cytometry and Cytokine Assays
Intracellular cytokine staining and ELISA are standard methods to quantify IL-10 production at the single-cell and population levels. These assays are used to validate CRISPR perturbations and to assess the effects of drugs or genetic variants on IL-10 production.
Metabolic and Mitochondrial Function Assays
Seahorse extracellular flux analysis, mitochondrial membrane potential dyes, and lipidomics can assess how metabolic pathways influence IL-10 production. These methods are particularly relevant for studying metabolic checkpoints in Tregs and other immune cells.
How CRISPR Can Be Used to Study GO:0032653 regulation of interleukin-10 production
Knockout
CRISPR knockout is used to delete candidate genes and assess their causal role in regulating IL-10 production. For example, knocking out GPR120 in CD4+ T cells can test its requirement for IL-10 production in colitis models. Knockout of transcription factors like STAT3 or MAF can confirm their essential roles in IL10 transcription.
Point Mutation
CRISPR point mutation knock-in allows researchers to introduce specific disease-associated variants into the endogenous locus and measure their impact on IL-10 production. This is valuable for studying how single-nucleotide polymorphisms in IL10 or its regulatory regions affect GO:0032653.
Knock-in
CRISPR knock-in can be used to tag endogenous IL-10 or its regulators with fluorescent proteins or epitope tags, enabling live tracking of IL-10 production and secretion. Knock-in of reporter cassettes (e.g., IL-10-GFP) facilitates high-throughput screening and single-cell analysis.
Overexpression
CRISPR-mediated overexpression (e.g., via CRISPRa) or lentiviral overexpression can test whether increasing the dosage of a candidate gene enhances IL-10 production. This approach is useful for validating positive regulators identified in screens.
How EDITGENE Supports regulation of interleukin-10 production Research
Researchers studying regulation of interleukin-10 production-related genes often need to determine whether a candidate gene is causally involved in controlling IL-10 output, and CRISPR-based models provide the most direct way to test this. EDITGENE offers a comprehensive suite of services to support such investigations.
Contact EDITGENE today to design your custom CRISPR model for regulation of interleukin-10 production research.
Frequently Asked Questions About regulation of interleukin-10 production
What is GO:0032653?
GO:0032653 is the Gene Ontology term for regulation of interleukin-10 production, defined as any process that modulates the frequency, rate, or extent of interleukin-10 production.
What genes are involved in regulation of interleukin-10 production?
Key genes include IL10, STAT3, MAF, NFKB1, PRDM1, FOXP3, GPR120, CD73, HMGCR, and many others involved in transcriptional, post-transcriptional, and metabolic control.
Which cells produce interleukin-10?
IL-10 is produced by CD4+ T cell subsets (Th1, Th2, Th17, Treg, Tr1), B cells, plasma cells, macrophages, dendritic cells, and NK cells.
How is IL-10 production regulated?
IL-10 production is regulated at transcriptional, post-transcriptional, translational, and secretory levels, as well as by metabolic and environmental signals.
What diseases are associated with dysregulated IL-10 production?
Dysregulated IL-10 production is associated with inflammatory bowel disease, autoimmunity, chronic infections, and cancer, including chronic lymphocytic leukemia.
How can CRISPR be used to study regulation of IL-10 production?
CRISPR knockout, knock-in, point mutation, and overexpression models allow causal testing of candidate genes in IL-10 regulation.
What is the role of GPR120 in IL-10 production?
GPR120 activation inhibits colitis through regulation of CD4+ T cell IL-10 production.
Does CD73 regulate IL-10?
Yes, CD73-dependent regulation of interferon αA and interleukin-10 occurs in inflamed mucosa.
Can statins affect IL-10 production?
Statins can affect IL-10 signaling and production by chronic lymphocytic leukemia cells.
What are the best methods to measure IL-10 production?
ELISA, intracellular cytokine staining, and flow cytometry are commonly used to quantify IL-10 production.
Conclusion
GO:0032653, regulation of interleukin-10 production, is a central biological process that controls the balance between protective immunity and immunopathology. Its dysregulation contributes to a wide range of human diseases, including inflammatory bowel disease, autoimmunity, and cancer. Advances in CRISPR-based functional genomics have made it possible to systematically identify and validate the genes and pathways that regulate IL-10 production. Continued research in this area promises to uncover new therapeutic targets for modulating IL-10 in disease settings.
References
- 1. Saraiva M et al.. 2010. The regulation of IL-10 production by immune cells.. Nat Rev Immunol 10(3):170-81 PMID: 20154735
- 2. Yang W et al.. 2022. GPR120 Inhibits Colitis Through Regulation of CD4(+) T Cell Interleukin 10 Production.. Gastroenterology 162(1):150-165 PMID: 34536451
- 3. Rutz S et al.. 2016. Regulation of Interleukin-10 Expression.. Adv Exp Med Biol 941:89-116 PMID: 27734410
- 5. Field CS et al.. 2020. Mitochondrial Integrity Regulated by Lipid Metabolism Is a Cell-Intrinsic Checkpoint for Treg Suppressive Function.. Cell Metab 31(2):422-437.e5 PMID: 31883840
- 6. Fillatreau S. 2015. Regulatory plasma cells.. Curr Opin Pharmacol 23:1-5 PMID: 25978519
- 7. Wang G et al.. 2025. Effect of statins on IL-10 signaling and production by chronic lymphocytic leukemia cells.. J Immunol 214(9):2453-2463 PMID: 40456521
- 8. Sotnikov I et al.. 2010. CD73-dependent regulation of interferon αA and interleukin-10 in the inflamed mucosa.. ScientificWorldJournal 10:2167-80 PMID: 21057730
